Adaptimmune, the T-cell therapy specialist, has said that new early-stage study data has outlined a development pathway for its lead product in a rare soft tissue cancer.
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho